Reska Biotech Stock

Reska Biotech Dividend 2025

Reska Biotech Dividend

0 USD

Reska Biotech Dividend yield

Ticker

GWIN

ISIN

US37961Q1013

How much dividend does Reska Biotech 2025 pay?

According to the latest status from June 2025, Reska Biotech paid a total of 0 USD per share in dividends within the last 12 months. With the current Reska Biotech price of 0.17 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Reska Biotech Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Reska Biotech Dividend Safe?

Reska Biotech has been increasing the dividend for 0 years.

Over the past 7 years, Reska Biotech has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Reska Biotech's Dividend Distributions

Reska Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Reska Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Reska Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Reska Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Reska Biotech Aktienanalyse

What does Reska Biotech do?

The Glorywin Entertainment Group Inc is a Hong Kong-based company that specializes in the production, management, and marketing of entertainment content. The company was founded in 2005 and has been listed on the Canadian stock exchange since 2015. Glorywin's business model is based on the production and marketing of entertainment content in various sectors. This includes film and television production, music labels, event management, as well as the management and marketing of artists and celebrities. Over the years, the company has developed and produced a variety of products. In the film and television sector, these include TV series such as "The Four Detective Guards," "Journey to the East," "Ten Deadly Sins," and "Saviors in the Forbidden City." In addition, Glorywin has also produced films for the cinema such as "The Four," "Kung Fu Angels," and "The White Storm." Musically, the company is primarily active in the Asian pop industry and operates its own label with well-known artists such as Coco Lee and Janice Vidal. Another important business area for Glorywin is event management. The company organizes concerts, festivals, and other events in China and other Asian countries. The most well-known events include the "MTV Super Summit," the "Pepsi Music Festival," and the "Hong Kong Asian-Pop Music Festival." Glorywin often collaborates with other companies to reach a wider audience. In addition to the production of entertainment content and event management, Glorywin also operates its own leisure facilities. The goal is to make the brand and products of the company accessible to a broader audience. The company primarily focuses on theme parks and interactive museums. Currently, Glorywin operates the "Three Kingdoms City" theme park in China and the "Cool & Ice World" museum in Hong Kong. In recent years, the company has also focused on the digital media sector. Glorywin operates its own social media platform for fans and has developed a chatbot system for interactive communication with customers. The goal is to position and market the brand and products even more strongly in the digital world. To coordinate and manage all these activities, Glorywin has built an experienced team of managers and producers. The company works closely with international partners and collaborators to develop innovative products and events that excite the audience and tap into new markets. Overall, the company has become an important player in the Asian entertainment industry in recent years and has achieved numerous successes. This success is supported by the increasing popularity of Asian pop music, TV series, and films worldwide. In the future, Glorywin will likely continue to focus on these trends and attempt to establish itself in new markets. Reska Biotech is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Reska Biotech stock

How much dividend does Reska Biotech pay?

Over the past 12 months, Reska Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Reska Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Reska Biotech?

The current dividend yield of Reska Biotech is .

When does Reska Biotech pay dividends?

Reska Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Reska Biotech?

Reska Biotech paid dividends every year for the past 0 years.

What is the dividend of Reska Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Reska Biotech located?

Reska Biotech is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von Reska Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Reska Biotech from 6/23/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/23/2025.

When did Reska Biotech pay the last dividend?

The last dividend was paid out on 6/23/2025.

What was the dividend of Reska Biotech in the year 2024?

In the year 2024, Reska Biotech distributed 0 USD as dividends.

In which currency does Reska Biotech pay out the dividend?

The dividends of Reska Biotech are distributed in USD.

Andere Kennzahlen von Reska Biotech

Our stock analysis for Reska Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Reska Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.